Life after Novartis: Jimenez joins board of Bayer-backed cell therapy startup

Joe Jimenez has (another) new gig. The ex-Novartis boss joined the board of Century Therapeutics, a startup working on off-the-shelf cell therapies that emerged last July with $250 million from the likes of Versant Ventures and Bayer’s VC arm.